These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32024824)

  • 21. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
    Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
    Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
    Morita K; Wang F; Jahn K; Hu T; Tanaka T; Sasaki Y; Kuipers J; Loghavi S; Wang SA; Yan Y; Furudate K; Matthews J; Little L; Gumbs C; Zhang J; Song X; Thompson E; Patel KP; Bueso-Ramos CE; DiNardo CD; Ravandi F; Jabbour E; Andreeff M; Cortes J; Bhalla K; Garcia-Manero G; Kantarjian H; Konopleva M; Nakada D; Navin N; Beerenwinkel N; Futreal PA; Takahashi K
    Nat Commun; 2020 Oct; 11(1):5327. PubMed ID: 33087716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal hematopoiesis and risk of acute myeloid leukemia.
    Young AL; Tong RS; Birmann BM; Druley TE
    Haematologica; 2019 Dec; 104(12):2410-2417. PubMed ID: 31004019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combinatorial approach for analyzing intra-tumor heterogeneity from high-throughput sequencing data.
    Hajirasouliha I; Mahmoody A; Raphael BJ
    Bioinformatics; 2014 Jun; 30(12):i78-86. PubMed ID: 24932008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
    Sallman DA; Komrokji R; Vaupel C; Cluzeau T; Geyer SM; McGraw KL; Al Ali NH; Lancet J; McGinniss MJ; Nahas S; Smith AE; Kulasekararaj A; Mufti G; List A; Hall J; Padron E
    Leukemia; 2016 Mar; 30(3):666-73. PubMed ID: 26514544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.
    Kubesova B; Pavlova S; Malcikova J; Kabathova J; Radova L; Tom N; Tichy B; Plevova K; Kantorova B; Fiedorova K; Slavikova M; Bystry V; Kissova J; Gisslinger B; Gisslinger H; Penka M; Mayer J; Kralovics R; Pospisilova S; Doubek M
    Leukemia; 2018 Feb; 32(2):450-461. PubMed ID: 28744014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation sequencing of oncogenes and tumor suppressor genes in odontogenic myxomas.
    Santos JN; Sousa Neto ES; França JA; Diniz MG; Moreira RG; Castro WH; Gomez RS; de Sousa SF; Gomes CC
    J Oral Pathol Med; 2017 Nov; 46(10):1036-1039. PubMed ID: 28597929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia.
    Heo SG; Koh Y; Kim JK; Jung J; Kim HL; Yoon SS; Park JW
    BMC Med Genet; 2017 Mar; 18(1):23. PubMed ID: 28249600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
    Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
    Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.
    Buelow DR; Pounds SB; Wang YD; Shi L; Li Y; Finkelstein D; Shurtleff S; Neale G; Inaba H; Ribeiro RC; Palumbo R; Garrison D; Orwick SJ; Blachly JS; Kroll K; Byrd JC; Gruber TA; Rubnitz JE; Baker SD
    Clin Transl Sci; 2019 Nov; 12(6):641-647. PubMed ID: 31350825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.
    Campanella NC; Silva EC; Dix G; de Lima Vazquez F; Escremim de Paula F; Berardinelli GN; Balancin M; Chammas R; Mendoza Lopez RV; Silveira HCS; Capelozzi VL; Reis RM
    Pathobiology; 2020; 87(3):208-216. PubMed ID: 32369821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.
    Kumar S; Warrell J; Li S; McGillivray PD; Meyerson W; Salichos L; Harmanci A; Martinez-Fundichely A; Chan CWY; Nielsen MM; Lochovsky L; Zhang Y; Li X; Lou S; Pedersen JS; Herrmann C; Getz G; Khurana E; Gerstein MB
    Cell; 2020 Mar; 180(5):915-927.e16. PubMed ID: 32084333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
    Bodini M; Ronchini C; Giacò L; Russo A; Melloni GE; Luzi L; Sardella D; Volorio S; Hasan SK; Ottone T; Lavorgna S; Lo-Coco F; Candoni A; Fanin R; Toffoletti E; Iacobucci I; Martinelli G; Cignetti A; Tarella C; Bernard L; Pelicci PG; Riva L
    Blood; 2015 Jan; 125(4):600-5. PubMed ID: 25499761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-Sensitive
    Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
    Front Immunol; 2019; 10():116. PubMed ID: 30891028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.